Curis Lifescien. Stock Price Today (NSE: CURIS)
Fundamental Score
Curis Lifescien. Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Curis Lifescien. share price today is ₹177.10, up +0.06% on NSE/BSE as of 6 November 2026. Curis Lifescien. (CURIS) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹82.62 (Cr). The 52-week high for CURIS share price is ₹234.75 and the 52-week low is ₹109.75. At a P/E ratio of 11.92x, CURIS is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 21.80% and a debt-to-equity ratio of 0.46.
Curis Lifescien. Share Price Chart — NSE/BSE Historical Performance
Curis Lifescien. share price chart: 2.03% return over the past month. 52-week high ₹234.75, 52-week low ₹109.75.
Curis Lifescien. — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹177.00 | ₹177.00 | ₹177.00 | ₹177.00 | 1.00K (Cr) | |
| ₹180.10 | ₹181.00 | ₹177.10 | ₹180.00 | 5.00K (Cr) | |
| ₹181.00 | ₹181.00 | ₹181.00 | ₹181.00 | 1.00K (Cr) | |
| ₹182.00 | ₹182.00 | ₹181.00 | ₹181.50 | 3.00K (Cr) | |
| ₹170.00 | ₹183.40 | ₹170.00 | ₹180.00 | 7.00K (Cr) | |
| ₹178.10 | ₹178.10 | ₹176.45 | ₹176.45 | 4.00K (Cr) | |
| ₹185.00 | ₹185.00 | ₹185.00 | ₹185.00 | 1.00K (Cr) | |
| ₹185.90 | ₹187.00 | ₹180.65 | ₹185.00 | 6.00K (Cr) | |
| ₹190.00 | ₹190.10 | ₹190.00 | ₹190.10 | 2.00K (Cr) | |
| ₹193.00 | ₹199.70 | ₹193.00 | ₹199.00 | 3.00K (Cr) |
Curis Lifescien. — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹177.00 | ₹177.00 | ₹177.00 | ₹177.00 | +0.00% | |
| ₹213.00 | ₹213.00 | ₹170.00 | ₹180.00 | -15.49% | |
| ₹142.90 | ₹234.75 | ₹137.00 | ₹217.30 | +52.06% | |
| ₹109.75 | ₹139.00 | ₹109.75 | ₹136.55 | +24.42% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Curis Lifescien. Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Curis Lifescien. Fundamental Analysis & Valuation Benchmarking
Educational evaluation of CURIS across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (21.80%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.25%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (17.62%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 11.92 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Strong Interest Coverage (9.39x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (68.03%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Profit Decline Concern (-31.66%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-12.53 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 6.99%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Curis Lifescien. vs Pharmaceuticals Peers
Peer Comparison -
Compare Curis Lifescien. with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
33.5/100 | ₹177.10₹177 | ₹82.62₹82.62 | 11.92Average 11.9 Average | 21.80%Excellent 21.80% Excellent | 21.25%Excellent 21.25% Excellent | 0.46Excellent 0.5 Excellent | — — | — — | 0.00% | |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 72.9/100 | ₹1758.80₹1759 | ₹421988.88₹421988.88 | 34.90Average 34.9 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 67.2/100 | ₹9144.50₹9145 | ₹242329.25₹242329.25 | 82.97Average 83.0 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 54.8/100 | ₹4558.90₹4559 | ₹154300.53₹154300.53 | 72.83Average 72.8 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 71.6/100 | ₹1123.00₹1123 | ₹112075.40₹112075.40 | 25.03Average 25.0 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 53.5/100 | ₹2060.10₹2060 | ₹111296.90₹111296.90 | 101.68Average 101.7 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 35.2/100 | ₹1325.10₹1325 | ₹107048.20₹107048.20 | 31.75Average 31.7 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 36.5/100 | ₹1233.00₹1233 | ₹102955.50₹102955.50 | 31.87Average 31.9 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1666.90₹1667 | ₹95913.43₹95913.43 | 26.05Average 26.0 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 59.7/100 | ₹2275.50₹2276 | ₹93978.15₹93978.15 | 45.98Average 46.0 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 77.1/100 | ₹1961.60₹1962 | ₹89694.16₹89694.16 | 16.21Average 16.2 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price421988.88 Cr
- Divi's Laboratories Limited share price242329.25 Cr
- Torrent Pharmaceuticals Limited share price154300.53 Cr
- Zydus Lifesciences Limited share price112075.40 Cr
- Laurus Labs Limited share price111296.90 Cr
Curis Lifescien. Quarterly Performance
Latest quarterly metrics for CURIS — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-4.77%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-31.66%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Curis Lifescien. Technical Indicators
SMA 50, SMA 200, RSI and volume signals for CURIS — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Curis Lifescien. Financial Statements
Annual income statement, balance sheet and cash flow for Curis Lifescien. (CURIS) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Curis Lifescien.
About CURIS (Curis Lifescien.)
Curis Lifescien. (CURIS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current ...market capitalisation of ₹82.62 (Cr). Curis Lifescien. has delivered a Return on Equity (ROE) of 21.80% and a ROCE of 21.25%. The debt-to-equity ratio stands at 0.46, reflecting the company's capital structure. Investors tracking CURIS share price can monitor key metrics including P/E ratio, promoter holding of 68.03%, and quarterly earnings growth.
Company Details
CURIS Share Price: Frequently Asked Questions
What is the current share price of Curis Lifescien.?
Curis Lifescien. (CURIS) trades at ₹177.10 on NSE. Market cap ₹82.62 (Cr). Educational data only.
What is the P/E ratio of Curis Lifescien.?
Curis Lifescien. has a P/E of 11.92x vs industry average 34.89x.
What is the Bull Run score for Curis Lifescien.?
Curis Lifescien. has a Bull Run score of 33.5/100 based on 25+ financial parameters.
Does Curis Lifescien. pay dividends?
Curis Lifescien. has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Curis Lifescien.?
Curis Lifescien. has ROE of 21.80%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Curis Lifescien.?
Curis Lifescien. has debt-to-equity of 0.46.
Is Curis Lifescien. a good investment?
Bull Run gives Curis Lifescien. a score of 33.5/100. This is not investment advice — consult a SEBI-registered advisor.